VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
PGR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
PGRThe Progressive Corporation
$234.40$137.0B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksPGRQuarterly Financials

The Progressive Corporation (PGR) Quarterly Financials

120+ quarters historyFree accessUpdated daily

The Progressive Corporation (PGR) quarterly income statement — complete revenue, gross profit & net income history

PGR Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue22.18B22.74B22.51B22B20.4B20.27B19.71B18.13B17.24B16.88B15.55B15.35B14.3B13.46B12.77B11.51B11.84B12.49B11.85B11.9B
Revenue Growth %8.71%12.19%14.21%21.34%18.36%20.04%26.74%18.11%20.56%25.41%21.75%33.3%20.8%7.83%7.78%-3.24%3.46%9.42%8.32%8.5%
Medical Costs & Claims13.83B16.08B18.96B15.12B14.26B14.44B13.9B13.9B12.2B12.7B12.56B13.32B11.74B10.87B10.99B10.35B9.82B9.82B10.2B9.34B
Medical Cost Ratio %62.34%70.72%84.24%68.72%69.9%71.23%70.52%76.7%70.8%75.19%80.76%86.81%82.11%80.77%86.03%89.94%82.98%78.64%86.08%78.45%
Gross Profit8.35B6.66B3.55B6.88B6.14B5.83B5.81B4.22B5.03B4.19B2.99B2.02B2.56B2.59B1.78B1.16B2.01B2.67B1.65B2.56B
Gross Margin %37.66%29.28%15.76%31.28%30.1%28.77%29.48%23.3%29.2%24.81%19.24%13.19%17.89%19.23%13.97%10.06%17.02%21.36%13.92%21.55%
Gross Profit Growth %36%14.15%-38.96%62.86%22.03%39.22%94.21%108.73%96.76%61.77%67.65%74.67%27.01%-2.91%8.14%-54.81%-41.7%-26.3%-51.38%-47.14%
Operating Expenses4.79B2.98B224M2.9B2.91B2.86B2.87B2.36B2.09B1.69B1.58B1.59B2B1.56B1.64B1.79B1.62B1.46B1.51B1.56B
OpEx / Revenue %21.58%13.08%1%13.17%14.24%14.13%14.54%13.04%12.14%9.98%10.17%10.35%14.01%11.62%12.86%15.59%13.72%11.72%12.75%13.15%
Depreciation & Amortization75M83M81M79M70M75.8M70.2M68M70M76.3M71.4M72.6M68M83.6M83.3M84M85.7M90.4M89.1M80.8M
Combined Ratio %83.92%83.81%85.24%81.9%84.14%85.36%85.06%89.74%82.94%85.17%90.93%97.16%96.12%92.38%98.88%105.52%96.7%90.36%98.83%91.6%
Operating Income3.57B3.68B3.32B3.98B3.24B2.97B2.94B1.86B2.94B2.5B1.41B435.7M554.4M1.03B142.5M-635.9M390.2M1.2B139M999.2M
Operating Margin %16.08%16.19%14.76%18.1%15.86%14.64%14.94%10.26%17.06%14.83%9.07%2.84%3.88%7.62%1.12%-5.52%3.3%9.64%1.17%8.4%
Operating Income Growth %10.2%24.06%12.84%114.09%10.07%18.55%108.82%326.9%430.3%144.16%889.61%168.52%42.08%-14.84%2.52%-163.64%-79.11%-42.84%-92.77%-55.96%
EBITDA3.64B3.77B3.4B4.06B3.31B3.04B3.02B1.93B3.01B2.58B1.48B508.3M622.4M1.11B225.8M-551.9M475.9M1.29B228.1M1.08B
EBITDA Margin %16.42%16.56%15.12%18.46%16.2%15.02%15.3%10.64%17.46%15.28%9.53%3.31%4.35%8.24%1.77%-4.79%4.02%10.37%1.92%9.08%
Interest Expense70M69M70M69M70M69.9M69.9M69M70M69.7M69.7M65.7M63.3M63.1M63.1M63M54.3M51.6M54.2M56.4M
Non-Operating Income-70M-69M-70M-69M-70M-69.9M-69.9M-69M-70M-69.7M-69.7M-65.7M-63.3M-63.1M-63.1M-63M-54.3M-51.6M-54.2M-56.4M
Pretax Income3.57B3.68B3.32B3.98B3.24B2.97B2.94B1.86B2.94B2.5B1.41B435.7M554.4M1.03B142.5M-635.9M390.2M1.2B139M999.2M
Pretax Margin %16.08%16.19%14.76%18.1%15.86%14.64%14.94%10.26%17.06%14.83%9.07%2.84%3.88%7.62%1.12%-5.52%3.3%9.64%1.17%8.4%
Income Tax748M731M708M807M669M611.4M611.4M401M609M515.6M288.9M90.3M106.5M198.9M18.4M-93M76.3M241.6M20.5M209.1M
Effective Tax Rate %20.98%19.85%21.31%20.27%20.67%20.6%20.76%21.56%20.71%20.6%20.49%20.73%19.21%19.4%12.91%14.62%19.55%20.07%14.75%20.93%
Net Income2.82B2.95B2.62B3.17B2.57B2.36B2.33B1.46B2.33B1.99B1.12B345.4M447.9M826.4M124.1M-542.9M313.9M962.3M118.5M790.1M
Net Margin %12.71%12.98%11.62%14.44%12.58%11.63%11.84%8.05%13.52%11.77%7.21%2.25%3.13%6.14%0.97%-4.72%2.65%7.71%1%6.64%
Net Income Growth %9.78%25.23%12.07%117.61%10.12%18.55%108.1%322.41%420.43%140.54%803.55%163.62%42.69%-14.12%4.73%-168.71%-78.79%-42.87%-92.26%-55.87%
EPS (Diluted)4.805.024.455.404.374.013.972.483.943.371.890.570.751.400.21-0.930.541.650.191.34
EPS Growth %9.84%25.19%12.09%117.74%10.91%18.99%110.05%335.09%425.33%140.71%800%161.29%38.89%-15.15%10.53%-169.4%-78.49%-42.71%-51.28%67.5%
EPS (Basic)4.815.044.455.424.384.023.982.493.953.381.900.570.751.400.21-0.930.541.650.191.34
Diluted Shares Outstanding586.9M588.2M588.2M587.8M587.7M587.65M587.6M587.4M587.3M587.5M587.5M587M587M587.1M587.1M586.5M586.3M584.7M587.1M586.8M